Trastuzumab - 20mg/ml in Histidine buffer (lyophilised powder)
CAS:
Ref. 3D-BT184541
1mg
341.00€
5mg
863.00€
10mg
1,356.00€
25mg
2,640.00€
Product Information
Name:Trastuzumab - 20mg/ml in Histidine buffer (lyophilised powder)
Synonyms:
- HerceptinImmunoglobulin G1Hervycta
Brand:Biosynth
Description:Trastuzumab is a humanised immunoglobulin G1 monoclonal antibody against human epidermal growth factor receptor 2 (HER2), used in breast cancer treatments. Some potential extracellular and intracellular antitumor mechanisms of trastuzumab have been proposed, including activation of antibody-dependent cellular cytotoxicity, inhibition of extracellular domain cleavage, abrogation of intracellular signalling, reduction of angiogenesis and decreased DNA repair that result in tumour cell stasis and/or death. Its drug conjugate, trastuzumab deruxtecan (T-DXd), is used in the clinical therapy for pretreated HER2-mutant non-small cell lung cancer (NSCLC).
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Technical inquiry about: Trastuzumab - 20mg/ml in Histidine buffer (lyophilised powder)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.